Papers Published:
  • Tiwari S, Kumar R, Devi S, Sharma P, Chaudhary NR, Negi S, Tandel N, Marepally S, Pied S, Tyagi RK. Biogenically synthesized green silver nanoparticles exhibit antimalarial activity. Discover Nano. 2024 Aug 31;19(1):136. doi: 10.1186/s11671-024-04098-2.
Papers Accepted:
  • Endocytosis as a critical regulator of hematopoietic stem cell fate—implications for hematopoietic stem cell and gene therapy. Prathibha babu chandraprabha and Saravanabhavan Thangavel. Stem cell research and therapy
  • Elizabeth Vinod, Ganesh Parasuraman, , Solomon Sathishkumar, Boopalan Ramasamy. Isolation of Articular Cartilage Resident Cells Chondrocytes, Fibronectin Adhesion Assay Derived and Migratory Chondroprogenitors. Journal of Visualized Experiments. Accepted on 31st August 2024.
  • Anila George, Poornasree Sadanandan, Nithin Sam Ravi, B Vaishnavi, Srujan Marepally , Saravanbhavan Thangavel Shaji R Velayudhan , Alok Srivastava, Mohankumar Kumarasamypet Murugesan. Editing of homologous globin genes by nickase deficient base editor mitigates large intergenic deletions in HSPCs. Journal of Molecular Therapy Nucleic Acids, (accepted on September 2024).
Invited talks :
  • Dr Saravanabhavan Thangavel is the Chief guest and Panelist for the symposium "Gene Editing and Clinical Trials” on 22nd Sep, 2024 at VIT, Vellore.
  • Dr Srujan Marepally delivered a talk titled “mRNA in lipid nanoparticles: Translational science ne banaadi jodi” on 24th August as a part of RNA SpARC WEBINAR SERIES, conducted by IISC-NCBS-Ignite foundation.
Others:
  • Dr Srujan Marepally invited to join as an editorial board member of Discover Nano Journal (Springer Nature group).